Skip to main content

Table 2 Project ENHANCE: summary of assessments, rationale, and schedule

From: Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population

Domain/Instrument

Rationale

Time point

Baseline

34 day follow-up

90 day follow-up

General measures, health status and other key characteristics

 Demographic characteristics (e.g., race, ethnicity, primary language of choice)

Description, moderators

X

  

 Hospitalization information (i.e., reason for and days of hospitalization)

Description, moderator

X

  

 General life, economic, housing, and criminal justice status

Description, moderators

X

  

 Usual source of medical care

Description, moderator

X

  

 Technology access and comfort

Description, moderator

X

  

 Cognitive function (Montreal Cognitive Assessment [MoCA]) [103]

Description, moderator

X

 

X

 Self-reported medical comorbidities [104]

Description

X

  

 Medication adherence [105,106,107]

Moderator

Xa

  

 Post-traumatic stress disorder

Description, moderator

X

  

 Patient reported outcomes (PROMIS-Preference [PROPr]) [108]

Moderators, Health utility score

Xa

Xa

Xa

 Project ENHANCE Informed consent quiz

Description

Xa

  

Alcohol-related measures

 Alcohol use history (lifetime, past 30 days)

Description, moderator

X

  

 AUDIT-C [43]

Description, moderator

X

  

 Alcohol symptom checklist [46]

Description, moderator

X

 

X

 Alcohol timeline followback [109]

Secondary outcome

X

X

X

 Formal alcohol treatment [110] and MAUD adherence [55]

Primary outcome

X

Xb

Xb

 Phosphatidylethanol (PEth) [111]

Secondary outcome

X

X

X

 Perspectives on treatment for alcohol use disorder [112, 113]

Description, moderator

X

  

 Alcohol readiness ruler

Description, moderator

Xa

Xb

Xb

 Alcohol abstinence self-efficacy scale [114]

Mediator

Xa

Xa

Xa

 Short Inventory of problems-revised [115]

Secondary outcome

Xa

 

Xa

Other substance use-related measures

 Drug use, past 30 days and age of first use

Moderators

X

  

 Opioid use disorder symptoms [116]

Moderator

X

  

 Severity of drug use problems (ASSIST Lite) [117]

Moderator

X

 

X

 Drug timeline followback

Moderator

X

X

X

 Substance use treatment history

Description

X

  

 Family history

Moderator

X

  

Additional social determinants of health

 Health disparities and safety screening tool, adapted [118, 119]

Moderators

Xa

  

 Medical mistrust and discrimination assessment [120]

Moderator

Xa

  

 Everyday discrimination scale [121]

Moderator

Xa

  

 Perceived racial discrimination-adapted

Moderator

Xa

  

 Immigration policy enforcement and related stress [122, 123]

Moderator

Xa

  

 Multidimensional acculturative stress inventory for adults of Mexican origin [124]

Moderator

Xa

  

 Multigroup ethnic identity measure-revised [125]

Moderator

Xa

  

Treatment services and adverse events

 Program and client costs (PACC-SAT) [126,127,128]

Treatment utilization and cost, mediator

X

X

 

 Adverse events (SAFTEE) [129]

Safety outcome

 

X

X

Process measures

 Project EHNANCE session completion, duration

Process

BNI and telephone booster

 Yale adherence and competence rating scale, adapted [130]

Intervention fidelity

BNI sessions only

Implementation-related measures

 Cost-related data

Cost effectiveness

X

X

X

 Participant satisfaction

Evaluation

 

Xa

Xa,c

  1. aIndicates participant self-administered via survey
  2. bVerified with objective measures at follow-up for outcome ascertainment [55, 131]
  3. cCompleted at 90 day assessment only if not completed at 34 day assessment